In the first one, a 74-year-old MG patient treated with mycophenolate, prednisone and eculizumab received both doses of the Pfizer BNT162b2, which failed to induce detectable specific circulating IgG or IFN-gamma T-cell responses. Here, IFNG is linked to myasthenia gravis.